Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.5K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.6K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.6K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

6.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.9K
Analgesia and Pain Management01:25

Analgesia and Pain Management

3.1K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.1K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

952
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
952
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

4.9K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular Mechanisms of Transcranial Magnetic Stimulation in Climbing Fibers and Purkinje Neurons in the Cerebellum.

bioRxiv : the preprint server for biology·2026
Same author

Conductivity Deviations as Virtual Sources in Magnetoencephalography.

Brain topography·2026
Same author

Experimental evaluation of an integrated focused ultrasound and electroencephalography approach for developing activation-informed neuroimaging.

NeuroImage·2026
Same author

Risk Factors Associated with Secondary Measles Transmission in Index Cases.

Journal of epidemiology·2026
Same author

Biplanar Nulling Coil System for OPM-MEG Using Printed Circuit Boards.

Sensors (Basel, Switzerland)·2025
Same author

Geodemographic analysis of socioeconomic area disparities in tuberculosis incidence in Osaka City, Japan.

Scientific reports·2025

Related Experiment Video

Updated: Apr 12, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

34.4K

Developmental potential for endomorphin opioidmimetic drugs.

Yoshio Okada1, Yuko Tsuda1, Severo Salvadori2

  • 1Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Chuo-ku, Kobe 650-8586, Japan.

International Journal of Medicinal Chemistry
|May 9, 2015
PubMed
Summary

Researchers developed novel opioid drugs based on endomorphins. These new compounds selectively target μ-opioid receptors, offering potent pain relief without the severe side effects of traditional opioids.

More Related Videos

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

9.3K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

3.5K

Related Experiment Videos

Last Updated: Apr 12, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

34.4K
Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

9.3K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

3.5K

Area of Science:

  • Pharmacology
  • Neuroscience
  • Medicinal Chemistry

Background:

  • Morphine and its derivatives (naloxone, naltrexone) are widely used for pain, addiction, and alcohol abuse but cause significant side effects.
  • Endogenous opioid peptides, endomorphin-1 and endomorphin-2, show high affinity and selectivity for μ-opioid receptors.
  • Existing exogenous opioids have limitations due to side effects and poor bioavailability.

Purpose of the Study:

  • To develop novel, efficacious opioid-based drugs with improved stability and bioavailability.
  • To create selective μ-opioid receptor antagonists with reduced adverse effects.
  • To overcome the limitations of current opioid therapies.

Main Methods:

  • Modified endomorphin-1 and endomorphin-2 by replacing N-terminal tyrosine with 2',6'-dimethyl-l-tyrosine (Dmt).
  • Systematically altered specific residues of [Dmt(1)]EM-1 and [Dmt(1)]EM-2 to create analogues.
  • Tested analogues for μ-opioid receptor antagonism in vivo (naloxone/naltrexone-induced withdrawal in mice) and in vitro (alcohol-induced changes in sIPSC in hippocampal slices).

Main Results:

  • Developed analogues [N-allyl-Dmt(1)]EM-1 (47) and [N-allyl-Dmt(1)]EM-2 (48) with potent and selective μ-receptor antagonism.
  • These analogues completely inhibited morphine-induced withdrawal symptoms in mice.
  • The novel compounds reversed alcohol-induced synaptic changes in hippocampal slices.
  • Developed drugs demonstrated resistance to enzymatic degradation and good epithelial membrane transport (gastrointestinal tract and blood-brain barrier).

Conclusions:

  • Novel endomorphin analogues ([N-allyl-Dmt(1)]EM-1 and [N-allyl-Dmt(1)]EM-2) are effective μ-opioid receptor antagonists.
  • These compounds represent a new class of opioid drugs with potential for treating pain and addiction without deleterious side effects.
  • Enhanced stability and bioavailability facilitate therapeutic application.